Idexx Laboratories
IDXX
1,116 hedge funds and large institutions have $36.7B invested in Idexx Laboratories in 2024 Q3 according to their latest regulatory filings, with 103 funds opening new positions, 363 increasing their positions, 431 reducing their positions, and 87 closing their positions.
18% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 87
1% more capital invested
Capital invested by funds: $36.4B → $36.7B (+$290M)
1% more funds holding
Funds holding: 1,110 → 1,116 (+6)
2.09% less ownership
Funds ownership: 90.59% → 88.5% (-2.1%)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
16% less repeat investments, than reductions
Existing positions increased: 363 | Existing positions reduced: 431
46% less call options, than puts
Call options by funds: $95M | Put options by funds: $176M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$129M |
| 2 |
Vontobel Holding
Zurich,
Switzerland
|
+$104M |
| 3 |
Barclays
London,
United Kingdom
|
+$100M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$76.6M |
| 5 |
Amundi
Paris,
France
|
+$61.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$343M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$159M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$115M |
| 4 |
BlackRock
New York
|
-$91.3M |
| 5 |
SC
Saturna Capital
Bellingham,
Washington
|
-$80.4M |
IDXX Hedge Fund Activity: Q3 2024 in Review
1,116 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2024, worth a combined $36.7B — up 0.8% from $36.4B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new IDXX positions and 87 closed out — a net gain of 16 holders — while 363 added to existing stakes and 431 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $129M. The largest seller was Winslow Capital Management, cutting an estimated $343M.
- 1,116 institutional investors held Idexx Laboratories (IDXX) as of Q3 2024, up from 1,110 in Q2 2024.
- Funds reported $36.7B of Idexx Laboratories stock for Q3 2024, up 0.8% quarter-over-quarter.
- 103 funds opened new Idexx Laboratories positions in Q3 2024 and 87 closed out, a net change of +16 holders.
- The largest Idexx Laboratories buyer in Q3 2024 was T. Rowe Price Associates, an estimated $129M added.
- The largest Idexx Laboratories seller in Q3 2024 was Winslow Capital Management, an estimated $343M sold.
Based on aggregated 13F filings for Q3 2024.